Get trade alerts

PACS Group ($PACS) Insider Trading & Smart Money Activity

PACS Group, Inc. · Medical Care Facilities · Latest filing Oct 16, 2026

PACS Group, Inc. ($PACS) has 13 insider trades and 2 13F position changes on file. In the last 12 months on the open market, no insider bought and 5 insiders sold ($24.13M), net -$24.13M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
5
Net insider $ (12 mo)
-$24.13M
Congress trades (12 mo)
0
13F moves on file
2
Analyst ratings on file
0

PACS insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 4 · $11.66M 0 / 0 0 / 2
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 9 · $12.47M 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All PACS insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Jason Hulse MurrayCo-Founder, CEO & Chairman Sell (Open-market sale) 10b5-1 8.46K sh $402.88K -0.02% SEC Read
Insider Jason Hulse MurrayCo-Founder, CEO & Chairman Sell (Open-market sale) 10b5-1 110.03K sh $5.20M -0.20% SEC Read
Insider Jason Hulse MurrayCo-Founder, CEO & Chairman Sell (Open-market sale) 10b5-1 232 sh $10.44K 0% SEC —
Insider Joshua JergensenPresident & COO Sell (Open-market sale) 10b5-1 40K sh $1.78M -1.60% SEC Read
Insider Murray Jason HulseCo-Founder, CEO & Chairman Sell (Open-market sale) 10b5-1 717 sh $30.46K +4.1% —
Insider Murray Jason HulseCo-Founder, CEO & Chairman Sell (Open-market sale) 10b5-1 35.98K sh $1.55M +3.7% —
Insider Murray Jason HulseCo-Founder, CEO & Chairman Sell (Open-market sale) 10b5-1 24.22K sh $1.03M +3.7% —
Insider Murray Jason HulseCo-Founder, CEO & Chairman Sell (Open-market sale) 10b5-1 26.05K sh $1.11M +1.1% —
Insider Murray Jason HulseCo-Founder, CEO & Chairman Sell (Open-market sale) 10b5-1 33.03K sh $1.36M +6.6% —
Insider Mark HancockCo Fndr; Exec V Chair Sell (Open-market sale) 10b5-1 61.93K sh $2.51M +7.4%+12.4% —
Insider Lewis Michelle ReneeChief Accounting Officer Sell (Open-market sale) 10b5-1 15K sh $600.15K +9.3%+15.7% —
Insider Mark HancockCo Fndr; Exec V Chair Sell (Open-market sale) 10b5-1 138.07K sh $5.57M +9.3%+15.7% Read
Insider Mark HancockCo Fndr; Exec V Chair Sell (Open-market sale) 10b5-1 83.07K sh $2.98M +4.1%+27.1% —
13F Cohen & Steers Reduced -374.64K sh $330.99M +0.7%-3.3% —
13F Cohen & Steers Reduced -374.64K sh $389.01M +0.7%-3.3% —

1W / 1M / 6M = how PACS moved from the trade or filing date.

Insider trading in PACS: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Jason Hulse Murray Co-Founder, CEO & Chairman 3 -$5.61M 54.32M Oct 16, 2026
Joshua Jergensen President & COO 1 -$1.78M 2.46M Oct 14, 2026
Murray Jason Hulse Co-Founder, CEO & Chairman 5 -$5.08M Oct 7, 2026
Mark Hancock Co Fndr; Exec V Chair 3 -$11.06M Jun 26, 2026
Lewis Michelle Renee Chief Accounting Officer 1 -$600.15K Jun 25, 2026

Institutions moving PACS (13F)

Frequently asked questions

Are PACS insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 5 insiders made 13 open-market sales worth $24.13M, a net -$24.13M.

What is the latest insider trade in PACS?

Jason Hulse Murray, Co-Founder, CEO & Chairman filed a sell (open-market sale) of 8.46K sh worth $402.88K on Oct 16, 2026.

Which institutions changed their PACS positions?

Recent 13F filers moving the stock include Cohen & Steers.

Other medical care facilities stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text